Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,955 | 15,909 | 41,980 | 145,523 | -11,016 |
| Depreciation Amortization | 79,322 | 98,708 | 54,454 | 40,318 | 35,029 |
| Income taxes - deferred | 15,615 | -7,945 | 10,872 | -126,613 | -1,828 |
| Accounts receivable | -7,159 | -2,079 | -10,434 | -5,516 | -8,524 |
| Accounts payable and accrued liabilities | 916 | 6,272 | -10,262 | -3,312 | -1,822 |
| Other Working Capital | -45,777 | -16,433 | -25,509 | -19,182 | 9,730 |
| Other Operating Activity | 69,777 | 50,842 | 64,616 | 45,814 | 48,951 |
| Operating Cash Flow | $154,649 | $145,274 | $125,717 | $77,032 | $70,520 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,758 | -13,000 | -17,187 | -1,160 | -1,622 |
| PPE Investments | -15,161 | -30,076 | -45,866 | -37,801 | -10,159 |
| Net Acquisitions | N/A | -32,000 | -424,042 | N/A | -117,691 |
| Purchase Of Investment | -137,608 | -387,685 | -602,431 | -546,516 | -318,484 |
| Sale Of Investment | 237,068 | 237,576 | 1,068,736 | 307,870 | 319,468 |
| Investing Cash Flow | $77,541 | $-225,185 | $-20,790 | $-277,607 | $-128,488 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 149,550 | N/A | 363,750 | 402,500 | N/A |
| Debt Repayment | -330,312 | -427,694 | N/A | -209,882 | -571 |
| Common Stock Issued | 4,750 | 27,341 | 26,655 | 47,764 | 10,871 |
| Other Financing Activity | -7,019 | -1,175 | -9,711 | -18,078 | -6,630 |
| Financing Cash Flow | $-183,031 | $-401,528 | $380,694 | $222,304 | $3,670 |
| Beginning Cash Position | 104,139 | 585,578 | 99,957 | 78,228 | 132,526 |
| End Cash Position | 153,298 | 104,139 | 585,578 | 99,957 | 78,228 |
| Net Cash Flow | $49,159 | $-481,439 | $485,621 | $21,729 | $-54,298 |
| Free Cash Flow | |||||
| Operating Cash Flow | 154,649 | 145,274 | 125,717 | 77,032 | 70,520 |
| Capital Expenditure | -15,161 | -30,076 | -45,866 | -37,801 | -10,159 |
| Free Cash Flow | 139,488 | 115,198 | 79,851 | 39,231 | 60,361 |